首页> 美国卫生研究院文献>Journal of Clinical Translational Endocrinology >The chlorite-based drug WF10 constantly reduces hemoglobin A1c values and improves glucose control in diabetes patients with severe foot syndrome
【2h】

The chlorite-based drug WF10 constantly reduces hemoglobin A1c values and improves glucose control in diabetes patients with severe foot syndrome

机译:基于亚氯酸盐的药物WF10不断降低严重脚综合征的糖尿病患者的血红蛋白A1c值并改善血糖控制

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

class="kwd-title">Keywords: Foot ulcers, Healing, WF10, HbA1c, Diabetes class="head no_bottom_margin" id="ab0020title">AbstractAimsThe intravenous application of the chlorite-based drug solution WF10 is known to improve wound healing in patients with diabetic foot syndrome. In this retrospective study, we addressed the question, which effects are caused by this drug in patients with diabetic foot ulcers on the hemoglobin A1c value.
机译:<!-fig ft0-> <!-fig @ position =“ anchor” mode =文章f4-> <!-fig mode =“ anchred” f5-> <!-fig / graphic | fig / alternatives / graphic mode =“ anchored” m1-> class =“ kwd-title”>关键字:足溃疡,愈合,WF10,HbA1c,糖尿病 class =“ head no_bottom_margin” id =“目的目的静脉内施用基于亚氯酸盐的药物溶液WF10可以改善糖尿病足综合征患者的伤口愈合。在这项回顾性研究中,我们解决了这个问题,即该药物对糖尿病足溃疡患者的血红蛋白A1c值产生何种影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号